Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

TSXV:MIR - Post Discussion

MedMira Inc > FYI UK Reports 1st Case 'Deltacron' Hybrid Delta & Omicron
View:
Post by EtheGreat on Feb 19, 2022 5:27pm

FYI UK Reports 1st Case 'Deltacron' Hybrid Delta & Omicron

Also Omicron Sub-Variant 'BA.2' on the Rise + New HIV Variant ! - Rapid POC Diagnistics are the Future !(available online to order or right at Local Pharmacy) - MEDMIRA has best Efficacy & Quicker (Fast) Result Times , Buy More, Buy More, Buy More -- EtheGreat or Not ?
Comment by dospintos on Feb 19, 2022 7:15pm
I agree a 100% ,, ethegreat + $$$
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities